Document Detail


Hageman factor and its binding sites are present in senile plaques of Alzheimer's disease.
MedLine Citation:
PMID:  7987673     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hageman factor (HF) or factor XII participates in several defense systems of the body. These include coagulation, fibrinolysis and complement activation. We investigated the expression of HF and its mRNA in control and Alzheimer's disease (AD) brain, using immunohistochemistry and polymerase-chain reaction (PCR) techniques. HF mRNA was detected in control and AD brain extracts, indicating that HF can be produced by endogenous brain cells. HF-like immunoreactivity was present in residual serum of capillaries in both control and AD brain, consistent with its known presence in the circulation. In addition, AD senile plaques were stained. The staining was dramatically enhanced when AD sections were incubated with solutions containing HF, indicating that plaques contain not only HF but also binding sites for HF. The enhanced staining was eliminated by pretreatment of solutions with the HF-binding agent kaolin. It was also eliminated by pretreatment of sections with protamine, an agent which strongly binds to negative surfaces. These data suggest that negatively charged surfaces in plaques might bind HF in vivo. Since HF can be activated by contact with negative surfaces, locally released HF could be playing a role in initiating a variety of inflammatory responses in AD brain.
Authors:
O Yasuhara; D G Walker; P L McGeer
Related Documents :
2996733 - Noradrenergic alpha 2 binding sites in vagal dorsal motor nucleus and nucleus tractus s...
22531623 - Chiral self-assembly of lactose functionalized perylene bisimides as multivalent glycoc...
2252613 - Propranolol-sensitive and phenoxybenzamine-insensitive binding of norepinephrine to end...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Brain research     Volume:  654     ISSN:  0006-8993     ISO Abbreviation:  Brain Res.     Publication Date:  1994 Aug 
Date Detail:
Created Date:  1995-01-09     Completed Date:  1995-01-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0045503     Medline TA:  Brain Res     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  234-40     Citation Subset:  IM    
Affiliation:
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Alzheimer Disease / metabolism*,  pathology
Base Sequence
Binding Sites
Brain / metabolism*,  pathology*
Capillaries / metabolism,  pathology
Cerebral Cortex / metabolism
Cerebrovascular Circulation
DNA Primers
Factor XII / analysis,  biosynthesis*
Gene Expression
Humans
Immunohistochemistry
Molecular Sequence Data
Polymerase Chain Reaction
RNA, Messenger / analysis,  biosynthesis
Receptors, Cell Surface / analysis,  biosynthesis*
Reference Values
Temporal Lobe / metabolism*,  pathology
Chemical
Reg. No./Substance:
0/DNA Primers; 0/RNA, Messenger; 0/Receptors, Cell Surface; 9001-30-3/Factor XII

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immunohistochemical localization of kappa opioid receptors in the human frontal cortex.
Next Document:  Extensor- and flexor-like modulation within motor pools of the rat hindlimb during treadmill locomot...